MedPath

Measurement of volatile substances in the exhaled air of ventilated patients

Conditions
N18.5
Chronic kidney disease, stage 5
Registration Number
DRKS00029679
Lead Sponsor
niversitätsmedizin Göttingen Klinik für Allgemein-, Viszeral- und Kinderchirurgie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Patients with chronic kidney disease, who get dialysis three times a week and that can decide about their participation themself.
Healthy control subjects have no specific inclusion criteria.

Exclusion Criteria

Patients that are not awake or not able to decide about the participation. Patients that are dialysed less or more often than three times a week.
Healthy control subjects can not have any other diseases.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The development of the phenol concentration before and after dialysis is analyzed and compared with the concentrations of the control group. A correlation to the blood results is analyzed.<br>
Secondary Outcome Measures
NameTimeMethod
o secoundary outcome
© Copyright 2025. All Rights Reserved by MedPath